Non-Small Cell Lung Cancer Market Forecast: Industry Developments and Growth Potential
Oncology investors and drug developers alike are keeping a close eye on the NSCLC therapeutics market, as non-small cell lung cancer (NSCLC) — responsible for roughly 85% of all lung cancer diagnoses — continues to shift from conventional chemotherapy toward biomarker-guided and immune-based treatment. This transformation is reshaping the lung cancer market at large and cementing...
0 Yorumlar 0 hisse senetleri 267 Views 0 önizleme